Invention Grant
- Patent Title: Triazolopyrimidine compounds and uses thereof
- Patent Title (中): 三唑并嘧啶化合物及其用途
-
Application No.: US14977273Application Date: 2015-12-21
-
Publication No.: US09580437B2Publication Date: 2017-02-28
- Inventor: Ho Man Chan , Xiang-Ju Justin Gu , Ying Huang , Ling Li , Yuan Mi , Wei Qi , Martin Sendzik , Yongfeng Sun , Long Wang , Zhengtian Yu , Hailong Zhang , Ji Yue (Jeff) Zhang , Man Zhang , Qiong Zhang , Kehao Zhao
- Applicant: Ho Man Chan , Xiang-Ju Justin Gu , Ying Huang , Ling Li , Yuan Mi , Wei Qi , Martin Sendzik , Yongfeng Sun , Long Wang , Zhengtian Yu , Hailong Zhang , Ji Yue (Jeff) Zhang , Man Zhang , Qiong Zhang , Kehao Zhao
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Genomics Institute of the Novartis Research Foundation
- Agent Emily T. Wu
- Priority: WOPCT/CN2014/094644 20141223; WOPCT/CN2015/095320 20151123
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; A61K31/541 ; A61K31/551 ; A61K45/06 ; A61K31/5377
Abstract:
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.
Public/Granted literature
- US20160176882A1 TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF Public/Granted day:2016-06-23
Information query
